BenzingaOctober 23, 2026 at 2:30 AM NY4 Days Ago
HC Wainwright & Co. Downgrades Avalo Therapeutics to Neutral
HC Wainwright & Co. analyst Mitchell S. Kapoor downgrades Avalo Therapeutics (NASDAQ:AVTX) from Buy to Neutral.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga